PATENT CLAIM ANALYSIS

Application Number: 16119887
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-01
Patent Classification: ["435", "366000"]

Abstract:
The present invention provides methods to promote differentiation of pancreatic endoderm cells to pancreatic endocrine rich clusters and to enhance insulin expression in hormone-expressing cells.

Claim (Index 5):
The method of  claim 4 , wherein the pluripotent cells wherein the pancreatic endoderm cells are derived from are human pluripotent stem cells.

Metadata:
- Claim Count in Document: 33.0
- Percentile: 96.0
- Lexical Diversity: 1.18182
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15340418', '16119862', '13911829', '13708369', '13998883']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6900589185709184
- 35 USC 102 Novelty (BERT): 0.6105867557835549
- Combined Prediction Score: 0.6821117022921821
- Mean Citation Score: 578.6506139999998
- Max Citation Score: 644.7586
- Similarity Product: 477.97964090214975

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test